Differential methylation of CpG sites in two isoforms of myosin binding protein C, an important hypertrophic cardiomyopathy gene

Environmental and Molecular Mutagenesis

Volumn 52, Issue 2, 2011, Pages 161-164

  Meurs, Kathryn M ^a   Kuan, Mani ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Cardiac; Cardiomyopathy; CpG; Deamination

Indexed keywords

DNA; MYOSIN BINDING PROTEIN C;

ARTICLE; CARDIOMYOPATHY; CPG ISLAND; DEAMINATION; GENE MUTATION; HEART MUSCLE; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; PLACENTA; POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

CARDIOMEGALY; CARRIER PROTEINS; CPG ISLANDS; DNA METHYLATION; EXONS; HUMANS; MUSCLE PROTEINS; MUSCLE, SKELETAL; PROTEIN ISOFORMS;

EID: 79551593678     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20596     Document Type: Article

References (24)

1. Alcalai R, Seidman JG, Seidman CE. 2008. Genetic basis of hypertrophic cardiomyopathy from bench to the clinics. J Cardiovasc Electrophysiol 9: 104-110.
2. Antonarakis SE, Krawczak M, Cooper DN. 2001. The nature and mechanisms of human gene mutation. In: Scriver CR, Sly WS. editors. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill. pp 343-377.
3. Bashyam MD, Savithri GR, Kumar MS, Narasimhan C, Nallari P. 2003. Molecular genetics of familial hypertrophic cardiomyopathy (FHC). J Hum Genet 48: 55-64.
4. Bos JM, Ommen SR, Ackerman MJ. 2007. Genetics of hypertrophic cardiomyopathy: One, two or more diseases? Curr Opin Cardiol 22: 193-199.
5. Chen JX, Zheng Y, West M, Tang MS. 1998. Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res 58: 2070-2075.
6. Cooper DN, Krawczak M. 1999. Single base pair substitutions. In: Human Gene Mutations. Oxford: BIOS Scientific Publishers Limited. pp 109-162.
7. D'Cruz LG, Baboonian C, Phillimore HE, Taylor R, Elliott PM, Varnava A, Davison F, McKenna WJ, Carter ND. 2000. Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy. J Med Genet 37: e18.
8. Feng Z, Hu WH, Tang MS. 2006. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at P53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci USA 103: 15404-15409.
9. Issa JP. 2002. Epigenetic variation and human disease. J Nutr 132: 2388S-2392S
10. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at UCSC. Genome Res 12: 996-1006.
11. Keren A, Syrris P, McKenna WJ. 2008. Hypertrophic cardiomyopathy: The genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 5: 158-168.
12. Krawczak M, Ball EV, Cooper DN. 1998. Neighboring nucleotide effects on the rates of germ-line single base pair substitution in human genes. Am J Hum Genet 63: 474-488.
13. Li LC, Dahiya R. 2002. MethPrimer: Designing primers for methylation PCR. Bioinformatics 18: 1427-1431.
14. Marian AJ. 2002. Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol 17: 242-252.
15. Marian AJ. 2008. Genetic determinants of cardiac hypertrophy. Current Opin Cardiol 23: 199-205.
16. Meurs KM, Mealey KL. 2008. Evaluation of the flanking nucleotide sequences of sarcomeric hypertrophic cardiomyopathy substitution mutations. Mutat Res 642: 86-89.
17. Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ, Fananapazir L. 2000. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol 32: 1687-1694.
18. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. 2002. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking associated cancers. Oncogene 21: 7435-7451.
19. Sulewska A, Niklinska W, Kozlowski M, Minarowski L, Naumnik W, Niklinski J, Dabrowska K, Chyczewski L. 2007. DNA methylation in states of cell physiology and pathology. Folia Histochem Cytobiol 45: 149-158.
20. Van Driest SL, Will ML, Atkins DL, Ackerman MJ. 2002. A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood. Am J Cardiol 90: 1123-1127.
21. Walsh CP, Xu GL. 2006. Cytosine methylation and DNA repair. Curr Top Microbiol Immunol 301: 283-315.
22. Watkins H, Thierfelder L, Hwang DS, McKenna W, Seidman JG, Seidman CE. 1992. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 90: 1666-1671.
23. Watkins H, Thierfelder L, Anan R, Jarcho J, Matsumori A, McKenna WJ, Seidman JG, Seidman CE. 1993. Independent origin of identical beta cardiac myosin heavy chain mutations in hypertrophic cardiomyopathy. Am J Hum Genet 53: 1180-1185.
24. Watkins H, Anan R, Coviello D, Spirito P, Seidman JG, Seidman CE. 1995. A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy. Circulation 91: 2302-2305.